SAN CARLOS, Calif.--(BUSINESS WIRE)--

Natus Medical Incorporated today announced the product formerly known as BioMAP (Biological Marker of Auditory Processing) launched in November 2006 is now known as BioMARK. BioMARK is a software application for the Bio-logic Navigator Pro hearing diagnostic platform that was developed by the Company's Bio-logic division in partnership with the Northwestern University Auditory Neuroscience Laboratory (1).

BioMARK is an objective neurophysiological test used to identify and assess auditory processing disorders associated with learning impairments in children. Studies conducted by researchers at Northwestern have shown that the BioMARK response in children 8-12 years of age is abnormal in as many as 30% of children who have been diagnosed with certain learning disabilities. Children with abnormal BioMARK responses who subsequently undergo auditory training typically show clinical improvement as well as changes in their BioMARK response after training is completed, objectively demonstrating that the training has had a beneficial impact on their speech processing skills.

More information on the research behind BioMARK may be found at the Northwestern University Neuroscience Laboratory website:

http://www.communication.northwestern.edu/brainvolts/projects/clin

icaltechnology.php (Due to its length, this URL may need to be copied/pasted into your Internet browser's address field. Remove the extra space if one exists.)

About Natus Medical Incorporated

Natus is a leading provider of healthcare products used for the screening, detection, treatment, monitoring and tracking of common medical ailments such as hearing impairment, neurological dysfunction, epilepsy, sleep disorders, and newborn care. Product offerings include computerized neurodiagnostic systems for audiology, neurology, polysomnography, and neonatology, as well as newborn care products such as hearing screening systems, phototherapy devices for the treatment of newborn jaundice, head-cooling products for the treatment of brain injury in newborns, and software systems for managing and tracking disorders and diseases for public health laboratories.

BioMARK (TM) and Navigator Pro (R) are trademarks of Natus Medical Incorporated.

Additional information about Natus Medical can be found at www.natus.com.

Reference:

(1) BioMARK was developed by Nina Kraus, Trent Nicol, Erika Skoe, and Steven Zecker at Northwestern University Auditory Neuroscience Laboratory, Evanston, IL

Source: Natus Medical Incorporated